개인 맞춤형 의료 연구 동향
![]() |
Lee, Sun-Won
(고려대학교)
Lee, Kyu-Bum (고려대학교) Kang, Jae-Woo (고려대학교) Choi, Jae-Hoon (고려대학교) Oh, Jun-Ho (고려대학교) |
1 | W. G. Feero, et al., "Genomic Medicine: Genomic Medicine -- An Updated Primer.," New England Journal of Medicine, vol. 362, pp. 2001-2011, May 27 2010. DOI ScienceOn |
2 | E. R. Mardis, "A decade's perspective on DNA sequencing technology," Nature, vol. 470, pp. 198-203, Feb 10 2011. DOI ScienceOn |
3 | P. R. Burton, et al., "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls,:"Nature, vol. 447, pp. 661-678, Jun 7 2007. DOI ScienceOn |
4 | H. M. Cann, et al., "A human genome diversity cell line panel," Science, vol. 296, pp. 261-262, Apr 12 2002. |
5 | Y. Zhang and J. S. Liu, "Bayesian inference of epistatic interactions in case-control studies," Nature Genetics, vol. 39, pp. 1167-1173, Sep 2007. DOI ScienceOn |
6 | 김남신, 추인선, "차세대 시퀀싱 기술의 활용," 생화학 분자생물학 뉴스, vol. 12월호, 2009. |
7 | 김용성, "인체의 후성유전학 연구동향," 한국생명공학연구원 유전체의학연구센터, vol. 13호, 2009. |
8 | M. Esteller, "Cancer epigenomics: DNA methylomes and histone-modification maps," Nature Reviews Genetics, vol. 8, pp. 286-298, Apr 2007. DOI ScienceOn |
9 | J. Goecks, et al., "Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences," Genome Biology, vol. 11, pp. -, 2010. |
10 | F. W. Frueh, et al., "Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: Prevalence of related drug use," Pharmacotherapy, vol. 28, pp. 992-998, Aug 2008. DOI ScienceOn |
11 | S. B. Baylin and J. E. Ohm, "Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?," Nature Reviews Cancer, vol. 6, pp. 107-116, Feb 2006. DOI ScienceOn |
12 | A. L. Statham, et al., "Repitools: an R package for the analysis of enrichment-based epigenomic data," Bioinformatics, vol. 26, pp. 1662-1663, Jul 1 2010. DOI ScienceOn |
13 | F. W. Frueh, et al., "Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: Prevalence of related drug use," Pharmacotherapy, vol. 28, pp. 992-998, Aug 2008. DOI ScienceOn |
14 | Y. Liu, et al., "SKM-SNP: SNP markers detection method," Journal of Biomedical Informatics, vol. 43, pp. 233-239, 2010. DOI ScienceOn |
15 | C. K. Ting, et al., "Multi-objective tag SNPs selection using evolutionary algorithms," Bioinformatics, vol. 26, pp. 1446-1452, Jun 1 2010. DOI ScienceOn |
16 | X. Chen, et al., "A forest-based approach to identifying gene and gene-gene interactions," American Journal of Epidemiology, vol. 167, pp. S96-S96, Jun 1 2008. |
17 | T. Simon, et al., "Genetic Determinants of Response to Clopidogrel and Cardiovascular Events," New England Journal of Medicine, vol. 360, pp. 363-375, Jan 22 2009. DOI ScienceOn |
18 | T. Yin and T. Miyata, "Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - Rationale and perspectives," Thrombosis Research, vol. 120, pp. 1-10, 2007. DOI ScienceOn |
19 | X. Zhang, et al., "TEAM: efficient two-locus epistasis tests in human genome-wide association study," Bioinformatics, vol. 26, pp. i217-i227, Jun 15 2010. DOI ScienceOn |
20 | X. Wan, et al., "MegaSNPHunter: A learning approach to detect disease predisposition SNPs and high level interactions in genome wide association study," BMC bioinformatics, vol. 10, 2009. |
21 | M. D. Ritchie, et al., "Multifactor-dimensionality reduction reveals high-order interactions among estrogenmetabolism genes in sporadic breast cancer," American Journal of Human Genetics, vol. 69, pp. 138-147, Jul 2001 DOI ScienceOn |
22 | Y. J. Chung, et al., "Odds ratio based multifactordimensionality reduction method for detecting gene-gene interactions," Bioinformatics, vol. 23, pp. 71-76, Jan 1 2007. DOI ScienceOn |
23 | S. Y. Lee, et al., "Log-linear model-based multifactor dimensionality reduction method to detect genegene interactions," Bioinformatics, vol. 23, pp. 2589-2595, Oct 1 2007. DOI ScienceOn |
24 | N. J. Prescott, et al., "A nonsynonymous SNP in ATG 16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and 1BD5," Gastroenterology, vol. 132, pp. 1665-1671, May 2007. DOI ScienceOn |
25 | E. Y. M. G. Fung, et al., "Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus," Genes and Immunity, vol. 10, pp. 188-191, Mar 2009. DOI ScienceOn |
![]() |